Lataa...
Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia
BACKGROUND: Lenalidomide, an immunomodulatory agent, has activity in lymphoproliferative disorders. The authors, therefore, evaluated its effects on T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia (CLL). METHODS: To study the immunomodulatory effects of l...
Tallennettuna:
| Julkaisussa: | Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349201/ https://ncbi.nlm.nih.gov/pubmed/21858802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25983 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|